StandardStandard

All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma. / Hughes, D.; Hughes, D.A.; All Wales Strategy Group., [No Value].
2008 gol. Unknown, 2008.

Allbwn ymchwil: Llyfr/AdroddiadAdroddiad Comisiwn

HarvardHarvard

APA

Hughes, D., Hughes, D. A., & All Wales Strategy Group., N. V. (2008). All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma. (2008 gol.) Unknown.

CBE

MLA

Hughes, D., D.A. Hughes a [No Value] All Wales Strategy Group. All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma. 2008 udg. Unknown. 2008.

VancouverVancouver

Author

Hughes, D. ; Hughes, D.A. ; All Wales Strategy Group., [No Value]. / All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma. 2008 gol. Unknown, 2008.

RIS

TY - BOOK

T1 - All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma.

AU - Hughes, D.

AU - Hughes, D.A.

AU - All Wales Strategy Group., [No Value]

PY - 2008/1/1

Y1 - 2008/1/1

UR - http://www.wales.nhs.uk/sites3/Documents/371/lenalidomide%20Revlimid%20FAR.pdf

M3 - Commissioned report

BT - All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma.

PB - Unknown

ER -